# Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease

> **NCT05894343** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **MeiraGTx, LLC** · enrollment: 13 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **GENETIC:** AAV-GAD

## Key facts

- **NCT ID:** NCT05894343
- **Lead sponsor:** MeiraGTx, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-19
- **Primary completion:** 2029-10
- **Final completion:** 2029-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05894343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05894343, "Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05894343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*